1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide manufacturers
- Levovirin
-
- $293.00
-
2026-08-29
- CAS:206269-27-4
- Purity: 99.81%
- Supply Ability: 10g
|
| | 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide Basic information |
| Product Name: | 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide | | Synonyms: | 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide;1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide;1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide;1H-1,2,4-Triazole-3-carboxamide, 1-β-L-ribofuranosyl-;1-β-L-ribofuranosyl-1,2,4-triazole-3-carboxamide;L-Ribovirin | | CAS: | 206269-27-4 | | MF: | C8H12N4O5 | | MW: | 244.2 | | EINECS: | | | Product Categories: | Anti-virals, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals | | Mol File: | 206269-27-4.mol | ![1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide Structure](CAS/GIF/206269-27-4.gif) |
| | 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide Chemical Properties |
| solubility | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated), Water (Slightly) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic |
| | 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide Usage And Synthesis |
| Uses | Levovirin is a monocyclic L-nucleosides with type 1 cytokine-inducing activity. Levovirin is the L-enantiomer of Ribavirin (R414475) with similar immunomodulatory activity but does not have direct antiviral activity or hemolytic anemia. |
| | 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide Preparation Products And Raw materials |
|